Smoking and Psoriasis: What the Research Shows

Of all the lifestyle factors linked to psoriasis, smoking has some of the strongest and most consistent evidence behind it — considerably stronger than alcohol, and worth understanding in detail.

The Evidence for Increased Risk

A 2026 systematic review and dose-response meta-analysis covering 30 observational studies and more than 25 million participants found smoking associated with a 67% increased risk of developing psoriasis (summary relative estimate 1.67), with clear evidence of a dose-response relationship — meaning more cumulative smoking exposure (measured in pack-years) corresponded to progressively higher risk. Notably, even former smokers remained at meaningfully higher risk than people who never smoked (38% increased risk), suggesting the effect doesn't fully reverse after quitting, at least not immediately.

This is a substantially stronger association than the same meta-analysis found for alcohol (33% increased risk, and a weaker one after statistical adjustment) — smoking is, by this measure, the more significant modifiable risk factor of the two.

Smoking Also Affects Treatment Response

Beyond risk of developing psoriasis, smoking appears to reduce how well treatment works once someone has the condition. A meta-analysis found that smokers were significantly less likely to see disease improvement at 6 months compared to non-smokers (odds ratio 0.80). Specific findings across studies included: smokers switching biologic treatments more often due to poor efficacy, lower rates of achieving PASI-75 with conventional drug therapy, and a dose-dependent relationship — one study found smoking 20 cigarettes daily was linked to worse response specifically to ustekinumab, a biologic medication.

One study also found a clear severity gradient tied to smoking exposure: patients with greater tobacco exposure had a higher proportion of severe disease compared to those with less exposure.

Why Smoking Affects Psoriasis

Several biological mechanisms have been proposed. Polycyclic aromatic hydrocarbons and dioxin-like compounds in tobacco smoke may interfere with aryl hydrocarbon receptor (AhR) signaling — the same pathway involved in coal tar's therapeutic effect, but here activated inappropriately by cigarette smoke rather than in a controlled therapeutic way, potentially lowering the threshold for inflammation. Smoking also promotes oxidative stress and inflammatory cytokine signaling, and nicotine specifically may affect blood vessel formation (angiogenesis) through VEGF-related pathways relevant to psoriatic skin changes.

What This Means Practically

• Smoking cessation is one of the more evidence-backed lifestyle interventions relevant to psoriasis — supported by both risk-reduction and treatment-response data
• If you smoke and aren't seeing expected results from treatment, this is worth discussing directly with your dermatologist, since it's a documented factor in treatment non-response
• The risk reduction from quitting may take time — former smokers showed continued elevated risk in the data, so don't expect an immediate reset, though quitting remains clearly worthwhile for this and many other health reasons

Frequently Asked Questions

Does quitting smoking reverse psoriasis risk immediately?

Not immediately based on the available data — former smokers showed continued elevated risk compared to never-smokers, though this doesn't diminish the overall value of quitting for long-term health.

Is vaping the same risk as traditional smoking for psoriasis?

This specific question hasn't been directly studied with the same rigor as traditional cigarette smoking in the research reviewed here.

Next Steps

For the related research on alcohol, see our full alcohol and psoriasis article.

This article is for general educational purposes and is not a substitute for professional medical advice. If you're considering quitting smoking, your doctor can offer support and resources.

Sources & References

• Smoking, alcohol consumption, and psoriasis risk: a systematic review and dose-response meta-analysis of observational studies. PMC13279607
• Zhou H, et al. Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis. SAGE Journals